No Data
Huntington Bancshares' (NASDAQ:HBAN) Investors Will Be Pleased With Their Notable 68% Return Over the Last Year
Express News | sage therapeutics terminates the development of the experimental drug dalzanemdor
Will the US bank stocks remain strong? Morgan Stanley has listed a "shareholding" list, while JPMorgan anticipates that the upward trend is likely to continue.
After Trump announced his re-election as the President of the USA, bank stocks in the US once again gained market attention, with the kbw nasdaq bank index soaring over 10% on November 6th, currently at the highest level since February 2022.
Huntington Bancshares Analyst Ratings
Citigroup Adjusts Price Target on Huntington Bancshares to $21 From $18, Maintains Buy Rating
Citi Maintains Huntington Bancshares(HBAN.US) With Buy Rating, Announces Target Price $21
No Data
No Data
